#Agena biosciences pro#

The MassARRAY System is a highly sensitive, cost-effective, mass spectrometry-based platform designed for high-throughput genetic analysis.

#Agena biosciences pro#

The iPLEX Pro SARS-CoV-2 Panel runs on a single MassARRAY instrument, and enables clinical laboratories to process more than 6000 samples each day.

Labs can test large numbers of samples without sacrificing accuracy.” Agena Bioscience provides low-cost and high-throughput molecular testing solutions The iPLEX Pro SARS-CoV-2 Panel exhibits a limit of detection of 0.3 copies per uL. The single-reaction panel is said to target five regions of the viral genome to provide the accuracy and sensitivity needed in the evolving landscape of SARS-CoV-2 testing.Īgena Bioscience scientific affairs vice president Darryl Irwin said: “As the number of people being tested increases, panel sensitivity will be critical to ensuring proper patient management.

US-based life sciences and clinical diagnostics firm Agena Bioscience has launched the iPLEX Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus, which causes Covid-19.Īgena said that its new assay is one of the highest throughput SARS-CoV-2 tests available under the US FDA’s Emergency Use Authorization (EUA) programme.Īvailable at a low-price of less than $10 per sample, the panel would enable large-scale testing more accessible. The iPLEX Pro SARS-CoV-2 Panel works on a single MassARRAY instrument, enabling clinical laboratories to process more than 6000 samples each dayĪgena Bioscience announces EUA for SARS-CoV-2 Panel - MassARRAY System for SARS-CoV-2 Molecular Detection.